The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Open accessAbstract
Dipeptidyl peptidase-4 (DPP4) is a widely expressed enzyme transducing actions through an anchored transmembrane molecule and a soluble circulating protein.Both membrane-associated and soluble DPP4 exert catalytic activity, cleaving proteins containing a position 2 alanine or proline.DPP4-mediated enzymatic cleavage alternatively inactivates peptides or generates new bioactive moieties that may exert competing or novel activities.The widespread use of selective DPP4 inhibitors for the treatment of type 2 diabetes has heightened interest in the molecular mechanisms through which DPP4 inhibitors exert their pleiotropic actions.Here we review the biology of DPP4 with a focus on: 1) identification of pharmacological vs physiological DPP4 substrates; and 2) elucidation of mechanisms of actions of DPP4 in studies employing genetic elimination or chemical reduction of DPP4 activity.We review data identifying the roles of key DPP4 substrates in transducing the glucoregulatory, anti-inflammatory, and cardiometabolic actions of DPP4 inhibitors in both preclinical and clinical studies.Finally, we highlight experimental pitfalls and technical challenges encountered in studies designed to understand the mechanisms of action and downstream targets activated by inhibition of DPP4.(Endocrine Reviews 35: 992-1019, 2014) I. Introduction II.Molecular Biology of DPP4 A. Discovery, genomic organization, and superfamily of related enzymes B. Molecular function C. Regulation of DPP4 expression D. Post-translational modifications of DPP4 III.DPP4 Substrates A. Brain natriuretic peptide (BNP) B. Erythropoietin C. Eotaxin D. Gastrin-releasing peptide (GRP) E. Glucagon F. Glucagon-like peptide-1 (GLP-1) G. Glucagon-like peptide-2 (GLP-2) H. Glucose-dependent insulinotropic polypeptide (GIP) I. Granulocyte colony-stimulating factor (G-CSF) J. Granulocyte-macrophage CSF (GM-CSF) K. GHRH and IGF-1 L. High-mobility group box 1 (HMGB1) M. Macrophage-derived chemokine (MDC) N. Macrophage inflammatory protein-1 ␣ (MIP-1 ␣), chemokine (C-C motif) ligand 3-like 1 (CCL3L1), or LD78 O. Oxyntomodulin P. Pituitary adenylate cyclase-activating polypeptide (PACAP) Q. Neuropeptide Y (NPY) R. Peptide tyrosine tyrosine (PYY) S. Regulated on activation, normal T cell expressed and secreted (Rantes) T. Stromal cell-derived factor-1 (SDF-1) U. Substance P (SP) IV.Discovery of DPP4 as a Drug Target A. Selective DPP4 inhibitors, glucoregulatory substrates, and the treatment of type 2 diabetes B. Metabolic phenotypes in animal models of DPP4 deficiency V. Mechanism(s) of Action of DPP4 Inhibitors A. Selectivity of DPP4 inhibitors B. Mechanisms through which DPP4 inhibitors lower glucose C. Proof of concept and mechanisms for DPP4-dependent glucose control in humans
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Self-citationSaxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Self-citationMENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124 · cited 3×
“Infusion of [125 GIP [1–42] or [125 GLP-1 [7–36]NH2 into DPP4 rats resulted in substantially less N-terminal cleavage of these peptides (90), illustrating the critical role of DPP4 for incretin inactivation in vivo.”
BackgroundPituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B. K. C., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,058
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880
Self-citationDeacon, C. F., Nauck, M. A., Toft-Nielsen, M., Pridal, L., Willms, B., & Holst, J. J. (1995) · Diabetes · doi:10.2337/diab.44.9.1126 · Cited by 878
Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., et al. (2013) · Nature · doi:10.1038/nature12328 · Cited by 739
Ahrén, B., Landin-Olsson, M., Jansson, P.-A., Svensson, M., Holmes, D., & Schweizer, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031907 · Cited by 710
Structure and Chromosomal Localization of the Human Stromal Cell-Derived Factor 1 (SDF1) Gene
Shirozu, M., Nakano, T., Inazawa, J., Tashiro, K., Tada, H., Shinohara, T., & Honjo, T. (1995) · Genomics · doi:10.1006/geno.1995.1180 · Cited by 624
Hansen, L., Deacon, C. F., Ørskov, C., & Holst, J. J. (1999) · Endocrinology · doi:10.1210/endo.140.11.7143 · Cited by 595
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Lamers, D., Famulla, S., Wronkowitz, N., Hartwig, S., Lehr, S., Ouwens, D. M., Eckardt, K., Kaufman, J. M., Ryden, M., Müller, S., et al. (2011) · Diabetes · doi:10.2337/db10-1707 · Cited by 582
Scanlan, M. J., Raj, B. K., Calvo, B., Garin-Chesa, P., Sanz-Moncasi, M. P., Healey, J. H., Old, L. J., & Rettig, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5657 · Cited by 574
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.-M., Pierres, M., Nielsen, P. F., Ribel, U., Watanabe, T., Drucker, D. J., & Wagtmann, N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120069197 · Cited by 538
Self-citationCardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Self-citationDirect Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507
Pancreatic safety of incretin-based drugs–FDA and EMA assessment
Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T., & Rosebraugh, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1314078 · Cited by 498
Herman, G. A., Bergman, A., Stevens, C., Kotey, P., Yi, B., Zhao, P., Dietrich, B., Golor, G., Schrodter, A., Keymeulen, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1009 · Cited by 495
Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes
Lankas, G. R., Leiting, B., Roy, R. S., Eiermann, G. J., Beconi, M. G., Biftu, T., Chan, C.-C., Edmondson, S., Feeney, W. P., He, H., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2988 · Cited by 491
Ahrén, B., Gomis, R., Standl, E., Mills, D., & Schweizer, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2874 · Cited by 487
Harmar, A. J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J. R., Vaudry, D., Vaudry, H., Waschek, J. A., & Said, S. I. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01871.x · Cited by 471
CD26, let it cut or cut it down
De Meester, I., Korom, S., Van Damme, J., & Scharpé, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01486-3 · Cited by 451
A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-?-naphthylamide
Hopsu-Havu, V. K., & Glenner, G. G. (1966) · Histochemie · doi:10.1007/bf00577838 · Cited by 435
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
Rasmussen, H. B., Branner, S., Wiberg, F. C., & Wagtmann, N. (2003) · Nature Structural Biology · doi:10.1038/nsb882 · Cited by 424
Ahrén, B., Simonsson, E., Larsson, H., Landin-Olsson, M., Torgeirsson, H., Jansson, P.-A., Sandqvist, M., Båvenholm, P., Efendic, S., Eriksson, J. W., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.869 · Cited by 421
Deacon, C. F., Nauck, M. A., Meier, J., Hücking, K., & Holst, J. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6855 · Cited by 401
Baggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.063 · Cited by 372
Self-citationPancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
(2014) · New England Journal of Medicine · doi:10.1056/nejmx140026 · Cited by 372
Cardiovascular Actions of Incretin-Based Therapies
Ussher, J. R., & Drucker, D. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.301958 · Cited by 358
Self-citationProteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV
Mentlein, R., Dahms, P., Grandt, D., & Krüger, R. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90435-b · Cited by 349
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
Conarello, S. L., Li, Z., Ronan, J., Roy, R. S., Zhu, L., Jiang, G., Liu, F., Woods, J., Zycband, E., Moller, D. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631828100 · Cited by 347
Panjwani, N., Mulvihill, E. E., Longuet, C., Yusta, B., Campbell, J. E., Brown, T. J., Streutker, C., Holland, D., Cao, X., Baggio, L. L., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1937 · Cited by 346
Self-citationPhysiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
Drucker, D. J., & Yusta, B. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170317 · Cited by 342
Self-citationMatikainen, N., Mänttäri, S., Schweizer, A., Ulvestad, A., Mills, D., Dunning, B. E., Foley, J. E., & Taskinen, M.-R. (2006) · Diabetologia · doi:10.1007/s00125-006-0340-2 · Cited by 336
Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., & Norcross, M. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1865 · Cited by 332
Deacon, C. F., Hughes, T. E., & Holst, J. J. (1998) · Diabetes · doi:10.2337/diabetes.47.5.764 · Cited by 321
Fadini, G. P., Boscaro, E., Albiero, M., Menegazzo, L., Frison, V., de Kreutzenberg, S., Agostini, C., Tiengo, A., & Avogaro, A. (2010) · Diabetes Care · doi:10.2337/dc10-0187 · Cited by 318
Hansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309
Self-citationEngel, M., Hoffmann, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., Huber, R., Bode, W., Demuth, H.-U., & Brandstetter, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230620100 · Cited by 305
Zaruba, M.-M., Theiss, H. D., Vallaster, M., Mehl, U., Brunner, S., David, R., Fischer, R., Krieg, L., Hirsch, E., Huber, B., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.013 · Cited by 301
Deacon, C. F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3575 · Cited by 301
Colony stimulating factors and myeloid cell biology in health and disease
Hamilton, J. A., & Achuthan, A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.08.006 · Cited by 285
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM
Nauck, M. A., Wollschläger, D., Werner, J., Holst, J. J., Ørskov, C., Creutzfeldt, W., & Willms, B. (1996) · Diabetologia · doi:10.1007/s001250050613 · Cited by 285
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
Drucker, D. J., Shi, Q., Crivici, A., Sumner-Smith, M., Tavares, W., Hill, M., DeForest, L., Cooper, S., & Brubaker, P. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-673 · Cited by 276
Self-citationHsieh, J., Longuet, C., Baker, C. L., Qin, B., Federico, L. M., Drucker, D. J., & Adeli, K. (2010) · Diabetologia · doi:10.1007/s00125-009-1611-5 · Cited by 275
Self-citationDurinx, C., Lambeir, A., Bosmans, E., Falmagne, J., Berghmans, R., Haemers, A., Scharpé, S., & De Meester, I. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01634.x · Cited by 267
Pederson, R. A., White, H. A., Schlenzig, D., Pauly, R. P., McIntosh, C. H. S., & Demuth, H.-U. (1998) · Diabetes · doi:10.2337/diab.47.8.1253 · Cited by 267
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
Brothers, S. P., & Wahlestedt, C. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000100 · Cited by 267
Bergman, A. J., Stevens, C., Zhou, Y., Yi, B., Laethem, M., De Smet, M., Snyder, K., Hilliard, D., Tanaka, W., Zeng, W., et al. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.01.015 · Cited by 265
Sauvé, M., Ban, K., Momen, M. A., Zhou, Y.-Q., Henkelman, R. M., Husain, M., & Drucker, D. J. (2010) · Diabetes · doi:10.2337/db09-0955 · Cited by 264
Self-citationKnudsen, L. B., & Pridal, L. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00795-9 · Cited by 248
Yada, T., Sakurada, M., Ihida, K., Nakata, M., Murata, F., Arimura, A., & Kikuchi, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42256-3 · Cited by 247
Shirakawa, J., Fujii, H., Ohnuma, K., Sato, K., Ito, Y., Kaji, M., Sakamoto, E., Koganei, M., Sasaki, H., Nagashima, Y., et al. (2011) · Diabetes · doi:10.2337/db10-1338 · Cited by 246
Balas, B., Baig, M. R., Watson, C., Dunning, B. E., Ligueros-Saylan, M., Wang, Y., He, Y.-L., Darland, C., Holst, J. J., Deacon, C. F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1882 · Cited by 243
What do we know about the secretion and degradation of incretin hormones?
Deacon, C. F. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.007 · Cited by 241
Sitagliptin Exerts an Antinflammatory Action
Makdissi, A., Ghanim, H., Vora, M., Green, K., Abuaysheh, S., Chaudhuri, A., Dhindsa, S., & Dandona, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1544 · Cited by 241
Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A.-M., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3554 · Cited by 237
Lockie, S. H., Heppner, K. M., Chaudhary, N., Chabenne, J. R., Morgan, D. A., Veyrat-Durebex, C., Ananthakrishnan, G., Rohner-Jeanrenaud, F., Drucker, D. J., DiMarchi, R., et al. (2012) · Diabetes · doi:10.2337/db11-1556 · Cited by 237
Self-citationBroxmeyer, H. E., Hoggatt, J., O'Leary, H. A., Mantel, C., Chitteti, B. R., Cooper, S., Messina-Graham, S., Hangoc, G., Farag, S., Rohrabaugh, S. L., et al. (2012) · Nature Medicine · doi:10.1038/nm.2991 · Cited by 223
The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides
Zhu, L., Tamvakopoulos, C., Xie, D., Dragovic, J., Shen, X., Fenyk-Melody, J. E., Schmidt, K., Bagchi, A., Griffin, P. R., Thornberry, N. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212355200 · Cited by 221
Adipose Dipeptidyl Peptidase-4 and Obesity
Sell, H., Blüher, M., Klöting, N., Schlich, R., Willems, M., Ruppe, F., Knoefel, W. T., Dietrich, A., Fielding, B. A., Arner, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0496 · Cited by 218
Balkan, B., Kwasnik, L., Miserendino, R., Holst, J. J., & Li, X. (1999) · Diabetologia · doi:10.1007/s001250051445 · Cited by 209
Zhong, J., Rao, X., & Rajagopalan, S. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.012 · Cited by 208
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes
Torimoto, Y., Dang, N. H., Vivier, E., Tanaka, T., Schlossman, S. F., & Morimoto, C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2514 · Cited by 206
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.2090 · Cited by 202
Thornberry, N., & Weber, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780091028 · Cited by 202
Adams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B., & Wallner, B. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0447 · Cited by 202
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
Abu-Hamdah, R., Rabiee, A., Meneilly, G. S., Shannon, R. P., Andersen, D. K., & Elahi, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1296 · Cited by 200
On the origin of serum CD26 and its altered concentration in cancer patients
Cordero, O. J., Salgado, F. J., & Nogueira, M. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0728-1 · Cited by 198
Action and therapeutic potential of oxyntomodulin
Pocai, A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.001 · Cited by 191
Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis
Busso, N., Wagtmann, N., Herling, C., Chobaz-Péclat, V., Bischof-Delaloye, A., So, A., & Grouzmann, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62266-3 · Cited by 191
In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans1
Hartmann, B., Harr, M. B., Jeppesen, P. B., Wojdemann, M., Deacon, C. F., Mortensen, P. B., & Holst, J. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6717 · Cited by 191
Jamen, F., Persson, K., Bertrand, G., Rodriguez-Henche, N., Puech, R., Bockaert, J., Ahrén, B., & Brabet, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9387 · Cited by 190
Dipeptidyl-Peptidase IV Converts Intact B-Type Natriuretic Peptide into Its des-SerPro Form
Brandt, I., Lambeir, A.-M., Ketelslegers, J.-M., Vanderheyden, M., Scharpé, S., & De Meester, I. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.057638 · Cited by 189
Amino acid sequences of three bombesin-like peptides from canine intestine extracts.
Reeve, J. R., Walsh, J. H., Chew, P., Clark, B., Hawke, D., & Shively, J. E. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)81930-9 · Cited by 189
Liu, L., Liu, J., Wong, W. T., Tian, X. Y., Lau, C. W., Wang, Y.-X., Xu, G., Pu, Y., Zhu, Z., Xu, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195115 · Cited by 179
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
Kirby, M., Yu, D. M. T., O'connor, S., & Gorrell, M. D. (2010) · Clinical Science · doi:10.1042/cs20090047 · Cited by 179
Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E. E., Hu, H., Kato, A., Sakai, Y., Liu, H., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6331 · Cited by 179
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F., & Morimoto, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.481 · Cited by 178
Abbott, C. A., McCaughan, G. W., Baker, E., & Sutherland, G. R. (1994) · Immunogenetics · doi:10.1007/bf01246674 · Cited by 177 · cited 10×
“In the mouse, Dpp4 is found on chromosome 2 (2C2–2D), and interestingly, exon 21 and exon 22 are present as a single 156-bp exon (19, 20).”
BackgroundInfluentialFrohman, L. A., Downs, T. R., Heimer, E. P., & Felix, A. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114049 · Cited by 177
Zhong, J., Rao, X., Deiuliis, J., Braunstein, Z., Narula, V., Hazey, J., Mikami, D., Needleman, B., Satoskar, A. R., & Rajagopalan, S. (2013) · Diabetes · doi:10.2337/db12-0230 · Cited by 176
Lamont, B. J., Li, Y., Kwan, E., Brown, T. J., Gaisano, H., & Drucker, D. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci42497 · Cited by 174
Self-citationKröller-Schön, S., Knorr, M., Hausding, M., Oelze, M., Schuff, A., Schell, R., Sudowe, S., Scholz, A., Daub, S., Karbach, S., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs246 · Cited by 174
Niederkofler, E. E., Kiernan, U. A., O'Rear, J., Menon, S., Saghir, S., Protter, A. A., Nelson, R. W., & Schellenberger, U. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.790774 · Cited by 165
Flock, G., Baggio, L. L., Longuet, C., & Drucker, D. J. (2007) · Diabetes · doi:10.2337/db07-0697 · Cited by 164
Self-citationShigeta, T., Aoyama, M., Bando, Y. K., Monji, A., Mitsui, T., Takatsu, M., Cheng, X.-W., Okumura, T., Hirashiki, A., Nagata, K., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096479 · Cited by 163
Rieg, T., Gerasimova, M., Murray, F., Masuda, T., Tang, T., Rose, M., Drucker, D. J., & Vallon, V. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00259.2012 · Cited by 160
Self-citationWaget, A., Cabou, C., Masseboeuf, M., Cattan, P., Armanet, M., Karaca, M., Castel, J., Garret, C., Payros, G., Maida, A., et al. (2011) · Endocrinology · doi:10.1210/en.2011-0286 · Cited by 156
Self-citationDipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).
Kähne, T., Lendeckel, U., Wrenger, S., Neubert, K., ANSORGE, S., & Reinhold, D. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.4.1.3 · Cited by 155
Struyf, S., Proost, P., Schols, D., Clercq, E. D., Opdenakker, G., Lenaerts, J., Detheux, M., Parmentier, M., Meester, I. D., Scharpé, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4903 · Cited by 154
Pauly, R. P., Rosche, F., Wermann, M., McIntosh, C. H. S., Pederson, R. A., & Demuth, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23222 · Cited by 154
Proost, P., Menten, P., Struyf, S., Schutyser, E., Meester, I. D., & Damme, J. V. (2000) · Blood · doi:10.1182/blood.v96.5.1674 · Cited by 153
Fujita, Y., Wideman, R. D., Asadi, A., Yang, G. K., Baker, R. K., Webber, T. D., Zhang, T., Wang, R., Ao, Z., Warnock, G. L., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.049 · Cited by 153
Frohman, L. A., Downs, T. R., Williams, T. C., et al. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112679 · Cited by 153
Proost, P., Struyf, S., Schols, D., Opdenakker, G., Sozzani, S., Allavena, P., Mantovani, A., Augustyns, K., Bal, G., Haemers, A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.3988 · Cited by 149
Shin, E. D., Estall, J. L., Izzo, A. A., Drucker, D. J., & Brubaker, P. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.033 · Cited by 147
Self-citationDeacon, C. F., Wamberg, S., Bie, P., Hughes, T., & Holst, J. J. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720355 · Cited by 147
Roberge, J. N., Gronau, K. A., & Brubaker, P. L. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641190 · Cited by 142
Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1
Ohnuma, K., Uchiyama, M., Yamochi, T., Nishibashi, K., Hosono, O., Takahashi, N., Kina, S., Tanaka, H., Lin, X., Dang, N. H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609157200 · Cited by 140
Deacon, C. F., & Holst, J. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.824966 · Cited by 137
Bak, M. J., Albrechtsen, N. J. W., Pedersen, J., Hartmann, B., Christensen, M., Vilsbøll, T., Knop, F. K., Deacon, C. F., Dragsted, L. O., & Holst, J. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0941 · Cited by 137
Circulating and Tissue Forms of the Intestinal Growth Factor, Glucagon-Like Peptide-2
Brubaker, P. L., Crivici, A., Izzo, A. A., Ehrlich, P. F., Tsai, C.-H., & Drucker, D. J. (1997) · Endocrinology · doi:10.1210/endo.138.11.5482 · Cited by 135
Self-citationHartmann, B., Thulesen, J., Kissow, H., Thulesen, S., Ørskov, C., Röpke, C., Poulsen, S. S., & Holst, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.11.7752 · Cited by 134
Nakamura, K., Oe, H., Kihara, H., Shimada, K., Fukuda, S., Watanabe, K., Takagi, T., Yunoki, K., Miyoshi, T., Hirata, K., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0110-2 · Cited by 131
Keane, F. M., Nadvi, N. A., Yao, T., & Gorrell, M. D. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08051.x · Cited by 130
Unraveling oxyntomodulin, GLP1's enigmatic brother
Pocai, A. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0368 · Cited by 130
Christopherson, K. W., Cooper, S. H., Hangoc, G., & Broxmeyer, H. E. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00256-x · Cited by 129
Ayaori, M., Iwakami, N., Uto‐Kondo, H., Sato, H., Sasaki, M., Komatsu, T., Iizuka, M., Takiguchi, S., Yakushiji, E., Nakaya, K., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.003277 · Cited by 127
CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1
Ohnuma, K., Yamochi, T., Uchiyama, M., Nishibashi, K., Yoshikawa, N., Shimizu, N., Iwata, S., Tanaka, H., Dang, N. H., & Morimoto, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405266101 · Cited by 126
Ulmer, A. J., Mattern, T., Feller, A. C., Heymann, E., & Flad, H. ‐. (1990) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1990.tb02789.x · Cited by 125
El-Ouaghlidi, A., Rehring, E., Holst, J. J., Schweizer, A., Foley, J. E., Holmes, D., & Nauck, M. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1932 · Cited by 120
Direct evidence for the binding of rat liver DPP IV to collagen in vitro
HANSKI, C., Huhle, T., Gossrau, R., et al. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90378-3 · Cited by 115
Aaboe, K., Knop, F. K., Vilsbøll, T., Deacon, C. F., Holst, J. J., Madsbad, S., & Krarup, T. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01167.x · Cited by 115
Lambeir, A., Durinx, C., Proost, P., Damme, J. V., Scharpé, S., & Meester, I. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02982-9 · Cited by 114
Åhrén, B., & Hughes, T. E. (2004) · Endocrinology · doi:10.1210/en.2004-1174 · Cited by 111
Theiss, H. D., Vallaster, M., Rischpler, C., Krieg, L., Zaruba, M., Brunner, S., Vanchev, Y., Fischer, R., Gröbner, M., Huber, B., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.05.003 · Cited by 111
Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer
Bušek, P., Malík, R., & Šedo, A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00262-0 · Cited by 111
Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited
Burkey, B. F., Hoffmann, P. K., Hassiepen, U., Trappe, J., Juedes, M. J., & Foley, J. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00860.x · Cited by 111
Dipeptidyl Peptidase IV Inhibition Improves Cardiorenal Function in Overpacing-Induced Heart Failure
Gomez, N., Touihri, K., Matheeussen, V., Costa, A. M. D., Mahmoudabady, M., Mathieu, M., Baerts, L., Peace, A. J., Lybaert, P., Scharpé, S., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr146 · Cited by 109
Misumi, Y., Hayashi, Y., Arakawa, F., & Ikehara, Y. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90036-y · Cited by 108
Kim, S., Nian, C., Doudet, D. J., & McIntosh, C. H. S. (2008) · Diabetes · doi:10.2337/db08-1101 · Cited by 106
Meier, J. J., Gethmann, A., Nauck, M. A., Götze, O., Schmitz, F., Deacon, C. F., Gallwitz, B., Schmidt, W. E., & Holst, J. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00576.2005 · Cited by 104
GLP‐1 (9–36) Amide, Cleavage Product of GLP‐1 (7–36) Amide, Is a Glucoregulatory Peptide
Elahi, D., Egan, J. M., Shannon, R. P., Meneilly, G. S., Khatri, A., Habener, J. F., & Andersen, D. K. (2008) · Obesity · doi:10.1038/oby.2008.229 · Cited by 104
Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes
Muscelli, E., Casolaro, A., Gastaldelli, A., Mari, A., Seghieri, G., Astiarraga, B., Chen, Y., Alba, M., Holst, J. J., & Ferrannini, E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1205 · Cited by 103
Bombesin-Like Peptides: Of Ligands and Receptors
Spindel, E. R., Giladi, E., Segerson, T. P., & Nagalla, S. R. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50017-8 · Cited by 102
Gault, V. A., Parker, J. C., Harriott, P., Flatt, P. R., & O'Harte, F. P. M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750525 · Cited by 102
Frerker, N., Wagner, L., Wolf, R., Heiser, U. F., Hoffmann, T., Rahfeld, J., Schade, J., Karl, T., Naim, H. Y., Alfalah, M., et al. (2007) · Peptides · doi:10.1016/j.peptides.2006.09.027 · Cited by 99
Des-serine-proline brain natriuretic peptide 3–32 in cardiorenal regulation
Boerrigter, G., Costello‐Boerrigter, L. C., Harty, G. J., Lapp, H., & Burnett, J. C. J. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00569.2006 · Cited by 99
Aulinger, B. A., Bedorf, A., Kutscherauer, G., de Heer, J., Holst, J. J., Göke, B., & Schirra, J. R. J. (2013) · Diabetes · doi:10.2337/db13-1455 · Cited by 98
Yan, S., Marguet, D., Dobers, J., Reutter, W. G., & Fan, H. (2003) · European Journal of Immunology · doi:10.1002/eji.200323469 · Cited by 97
Iwata, S., Yamaguchi, N., Munakata, Y., Ikushima, H., Lee, J. F., Hosono, O., Schlossman, S. F., & Morimoto, C. (1999) · International Immunology · doi:10.1093/intimm/11.3.417 · Cited by 96
Nagakura, T., Yasuda, N., Yamazaki, K., Ikuta, H., Yoshikawa, S., Asano, O., & Tanaka, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4999 · Cited by 95
Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo.
Ahmad, S., Wang, L., & Ward, P. E. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11437-7 · Cited by 95
Fukasawa, K. M., Fukasawa, K. M., Sahara, N., Harada, M., Kondo, Y., & Nagatsu, I. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.3.6787113 · Cited by 94
Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
Eager, R., Cunningham, C. C., Senzer, N. N., Richards, D., Raju, R. N., Jones, B. N., Uprichard, M. J., & Nemunaitis, J. J. (2009) · Clinical Oncology · doi:10.1016/j.clon.2009.04.007 · Cited by 92
Struyf, S., Proost, P., Sozzani, S., Mantovani, A., Wuyts, A., Clercq, E. D., Schols, D., & Damme, J. V. (1998) · PubMed · Cited by 91
Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY
Unniappan, S., McIntosh, C. H. S., Demuth, H. U., Heiser, U. F., Wolf, R., & Kieffer, T. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0310-8 · Cited by 91
Kirino, Y., Sato, Y., Kamimoto, T., Kawazoe, K., Minakuchi, K., & Nakahori, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0424 · Cited by 91
Theiss, H. D., Brenner, C., Engelmann, M. G., Zaruba, M., Huber, B., Henschel, V., Mansmann, U., Wintersperger, B. J., Reiser, M., Steinbeck, G., et al. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.09.555 · Cited by 90
Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes
Scheen, A. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2659 · Cited by 90
Matheeussen, V., Waumans, Y., Martinet, W., Goethem, S. V., der Veken, P. V., Scharpé, S., Augustyns, K., Meyer, G. R. Y. D., & Meester, I. D. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0350-4 · Cited by 90
The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist
Thulesen, J., Knudsen, L. B., Hartmann, B., Hastrup, S., Kissow, H., Jeppesen, P. B., Ørskov, C., Holst, J. J., & Poulsen, S. S. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00316-0 · Cited by 90
Böhm, S. K., Gum, J. R., Erickson, R. H., Hicks, J. W., & Kim, Y. S. (1995) · Biochemical Journal · doi:10.1042/bj3110835 · Cited by 89
Maida, A., Hansotia, T., Longuet, C., Seino, Y., & Drucker, D. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.004 · Cited by 88
Self-citationCordero, O. J., Salgado, F. J., Mera, A., & Nogueira, M. (2001) · Rheumatology International · doi:10.1007/s002960100134 · Cited by 84
Kyle, K., Willett, T. L., Baggio, L. L., Drucker, D. J., & Grynpas, M. D. (2010) · Endocrinology · doi:10.1210/en.2010-1098 · Cited by 82
Self-citationFan, H., Meng, W., Kilian, C., Grams, S., & Reutter, W. G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00243.x · Cited by 81
Cuchacovich, M., Gatica, H., Pizzo, S. V., & Gonzalez–Gronow, M. (2001) · PubMed · Cited by 80
Struyf, S., Proost, P., Sozzani, S., Mantovani, A., Wuyts, A., Clercq, E. D., Schols, D., & Damme, J. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2672 · Cited by 79
Xiao, C., Dash, S., Morgantini, C., Patterson, B. W., & Lewis, G. F. (2014) · Diabetes · doi:10.2337/db13-1654 · Cited by 76
McCaughan, G. W., Wickson, J. E., Creswick, P. F., & Gorrell, M. D. (1990) · Hepatology · doi:10.1002/hep.1840110403 · Cited by 74
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells
Bauvois, B., Djavaheri‐Mergny, M., Rouillard, D., Dumont, J., & Wietzerbin, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203292 · Cited by 74
GIP-(3–42) does not antagonize insulinotropic effects of GIP at physiological concentrations
Deacon, C. F., Plamboeck, A., ROSENKILDE, M. M., de Heer, J., & Holst, J. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2005 · Cited by 72
Ikushima, H., Munakata, Y., Iwata, S., Ohnuma, K., Kobayashi, S., Dang, N. H., & Morimoto, C. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00010-2 · Cited by 70
Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
Pospisilik, J. A., Hinke, S. A., Pederson, R. A., Hoffmann, T., Rosche, F., Schlenzig, D., Glund, K., Heiser, U. F., McIntosh, C. H. S., & Demuth, H. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00170-1 · Cited by 70
Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV)
Vivier, I., Marguet, D., Naquet, P., BONICEL, J. J., Black, D. M., Li, C. X., Bernard, A., Gorvel, J., & Pierres, M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.447 · Cited by 68
Physiology and pathophysiology of incretins in the kidney
von Websky, K., Reichetzeder, C., & Hocher, B. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000437542.77175.a0 · Cited by 68
Chang, G., Zhang, P., Ye, L., Lü, K., Wang, Y., Duan, Q., Zheng, A., Qin, S., & Zhang, D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.007 · Cited by 67
Aertgeerts, K., Ye, S., Shi, L., Prasad, S. G., Witmer, D., Chi, E., Sang, B., Wijnands, R. A., Webb, D. R., & Swanson, R. V. (2003) · Protein Science · doi:10.1110/ps.03352504 · Cited by 66
Fadini, G. P., Albiero, M., Seeger, F. H., Poncina, N., Menegazzo, L., Angelini, A., Castellani, C., Thiene, G., Agostini, C., Cappellari, R., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0313-1 · Cited by 66
Solis‐Herrera, C., Triplitt, C. L., Garduño‐García, J. D. J., Adams, J., DeFronzo, R. A., & Cersósimo, E. (2013) · Diabetes Care · doi:10.2337/dc12-2072 · Cited by 66
Yu, D. M. T., Slaitini, L., Gysbers, V., Riekhoff, A. G. M., Kähne, T., Knott, H. M., Meester, I. D., Abbott, C. A., McCaughan, G. W., & Gorrell, M. D. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02488.x · Cited by 64
Expanding the Dipeptidyl Peptidase 4-Regulated Peptidome via an Optimized Peptidomics Platform
Tinoco, A. D., Tagore, D. M., & Saghatelian, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909524e · Cited by 64
Soluble DPP4 originates in part from bone marrow cells and not from the kidney
Wang, Z., Grigo, C., Steinbeck, J., von Hörsten, S., Amann, K., & Daniel, C. (2014) · Peptides · doi:10.1016/j.peptides.2014.05.006 · Cited by 64
Peptidase substrates via global peptide profiling
Tagore, D. M., Nolte, W. M., Neveu, J. M., Rangel, R., Guzman‐Rojas, L., Pasqualini, R., Arap, W., Lane, W. S., & Saghatelian, A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.126 · Cited by 63
Karl, T., Hoffmann, T., Pabst, R., & von Hörsten, S. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00229-4 · Cited by 63
Ku, H.-C., Chen, W., & Su, M. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0665-3 · Cited by 61
Bunck, M. C. M., Poelma, M., Eekhoff, E. M. W., Schweizer, A., Heine, R. J., Nijpels, G., Foley, J. E., & Diamant, M. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00168.x · Cited by 60
Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides
Tiruppathì, C., Miyamoto, Y., Ganapathy, V., & Leibach, F. H. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.265.1.g81 · Cited by 58
Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs
Ohnuma, K., Munakata, Y., Ishii, T., Iwata, S., Kobayashi, S., Hosono, O., Kawasaki, H., Dang, N. H., & Morimoto, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6745 · Cited by 58
Tsuji, E., Misumi, Y., Fujiwara, T., Takami, N., Ogata, S., & Ikehara, Y. (1992) · Biochemistry · doi:10.1021/bi00162a035 · Cited by 57
Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
Ceccarelli, E., Guarino, E., Merlotti, D., Patti, A., Gennari, L., Nuti, R., & Dotta, F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00073 · Cited by 55
Kim, S., Nian, C., & McIntosh, C. H. S. (2010) · Diabetes · doi:10.2337/db09-1618 · Cited by 55
High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
Marchetti, C., Di Carlo, A., Facchiano, F., Senatore, C., De Cristofaro, R., Luzi, A., Federici, M., Romani, M., Napolitano, M., Capogrossi, M. C., et al. (2012) · Diabetologia · doi:10.1007/s00125-011-2213-6 · Cited by 52
Yasuda, N., Nagakura, T., Yamazaki, K., Inoue, T., & Tanaka, I. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01637-5 · Cited by 52
Vora, K. A., Porter, G., Peng, R., Cui, Y., Pryor, K. D., Eiermann, G. J., & Zaller, D. M. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-19 · Cited by 50
Karl, T., Chwalisz, W. T., Wedekind, D., Hedrich, H. J., Hoffmann, T., Jacobs, R., Pabst, R., & von Hörsten, S. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00149-6 · Cited by 50
The enteroinsular axis in dipeptidyl peptidase IV-negative rats
Pederson, R. A., Kieffer, T. J., Pauly, R. P., Kofod, H., Kwong, J., & McIntosh, C. H. S. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90112-2 · Cited by 49
CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity
Guieu, R., Fenouillet, E., DEVAUX, C., Fajloun, Z., Carrega, L., Sabatier, J., Sauze, N., & Marguet, D. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.003 · Cited by 49
Hydrolysis of amino acidβ-naphthylamides by aminopeptidases in human parotid saliva and human serum
Nagatsu, I., Nagatsu, T., & Yamamoto, T. (1968) · Cellular and Molecular Life Sciences · doi:10.1007/bf02140813 · Cited by 42
Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor
Ansarullah, M., Lu, Y., Holstein, M., Brittany, D., Rabinovitch, A., & Guo, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053345 · Cited by 40
Theiss, H. D., Groß, L., Vallaster, M., David, R., Brunner, S., Brenner, C., Nathan, P., Assmann, G., Mueller‐Hoecker, J., Vogeser, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.121 · Cited by 40
Stange, T., Kettmann, U., & Holzhausen, H.-J. (1996) · Acta Histochemica · doi:10.1016/s0065-1281(96)80025-0 · Cited by 39
Differential regional metabolism of glucagon in anesthetized pigs
Deacon, C. F., Kelstrup, M., Trebbien, R., Klarskov, L., Olesen, M., & Holst, J. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00125.2003 · Cited by 39
Goodwin, S. R., Reeds, D. N., Royal, M., Struthers, H., Laciny, E., & Yarasheski, K. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3532 · Cited by 39
Smith, R. E., Talhouk, J. W., BROWN, E. E., & Edgar, S. E. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.851 · Cited by 38
Price, J. D., Linder, G., Li, W., Zimmermann, B., Rother, K. I., Malek, R., Alattar, M., & Tarbell, K. V. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12144 · Cited by 36
Hegen, M., Mittrücker, H.-W., Hug, R., Demuth, H., Neubert, K., Barth, A., & Fleischer, B. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80419-5 · Cited by 36
Davidson, J. A. (2013) · Endocrine Practice · doi:10.4158/ep12303.ra · Cited by 35
Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclear factor 1α
Erickson, R. H., Gum, J. R., Lotterman, C., HICKS, J. W., Lai, R. S., & Kim, Y. S. (1999) · Biochemical Journal · doi:10.1042/bj3380091 · Cited by 34
Delacour, D., Gouyer, V., Leteurtre, E., Aït‐Slimane, T., Drobecq, H., Lenoir, C., Moreau-Hannedouche, O., Trugnan, G., & Huet, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305755200 · Cited by 34
Batičić, L., Detel, D., Kučić, N., Buljević, S., Pugel, E. P., & Varljen, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23261 · Cited by 34
Cited by
Adipokines in health and disease
Fasshauer, M., & Blüher, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.014 · Cited by 1,050
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
The Cardiovascular Biology of Glucagon-like Peptide-1
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.009 · Cited by 665
Self-citationFluorogenic probes for disease-relevant enzymes
Zhang, J., Chai, X., He, X.-P., Kim, H.-J., Yoon, J., & Tian, H. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00907k · Cited by 606
Metadata
- Authors
- Mulvihill, E. E., & Drucker, D. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2014-09-12
- Volume
- 35
- Issue
- 6
- Pages
- 992-1019
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2131821161
- Cited by
- 609
- References
- 217
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.